Archived research. Equity forecasting is part of the Runchey Research archive (methodology era 1) and is no longer actively updated. Everything remains published at its original URL. Browse the archive
Will Xometry report FY 2026 Adjusted EBITDA at or above $40M?
Current Prediction
Why This Question Matters
Tests whether 20% incremental Adj EBITDA margin discipline holds through CEO transition (Sahni effective July 1, 2026). Black Swan Beacon Scenario B explicitly flagged transition friction breaking incremental margin track record as 10-20% probability MATERIAL risk. $40M reflects modest compression (from ~$50M central case) — the threshold where operating leverage thesis remains intact but no longer accelerating.
Prediction Distribution
Individual Predictions(9 runs)
FY 2025 base $18.5M + 20% incremental on $144M minimum revenue growth = $47M central case. Even with revenue at guide floor ($832M) + 15% incremental margin (vs 20% track record) = $40M flat. CEO transition friction (BSB Scenario B, 10-20%) is main downside. ~68%.
$40M needs only ~12.6% incremental at $855M revenue or ~15% at $832M floor — substantially below 20% track record. Marketplace GM expanding +80bp YoY adds tailwind. Risk: international segment investment acceleration could absorb $5-10M. ~65%.
Three-year incremental margin discipline track record is strong. Mgmt has explicit narrative incentive to demonstrate continuity through CEO transition. International segment narrowing losses. SBC at 5.3% of revenue stable, not accelerating. Lean YES with margin. ~72%.
Central case ~$50M, threshold $40M = 20% cushion. Incremental margin only needs 13-15% (vs 20% track). Mgmt continuity incentive. ~66%.
Q4 2025 exit run-rate strong. Marketplace GM expanding flows directly to EBITDA. Operating leverage discipline pattern across 3 years; year 4 typically continues. Tail: Sahni hiring/SBC spike in 2H. ~69%.
$40M = ~4.7% margin (on $855M) vs 2.7% in 2025. Doubling margin in one year is non-trivial; needs ~$22M improvement. Historical pace was $28M YoY (2024 to 2025). Pace continuation supports threshold. ~65%.
Threshold is moderate — 13-15% incremental vs 20% track record. Lean YES. ~67%.
Discipline pattern + mgmt incentive + GM expansion. ~68%.
Central case $47M, threshold $40M, transition tail risk. ~68%.
Resolution Criteria
Resolves YES if Xometry's reported full-year 2026 Adjusted EBITDA (as defined in the company's non-GAAP reconciliation in the FY 2026 10-K or Q4 2026 earnings release) is at or above $40.0M. Resolves NO if below $40.0M.
Resolution Source
Xometry FY 2026 10-K filing or Q4 2026 earnings release
Source Trigger
Incremental Adj EBITDA margin below 15% for 2 consecutive quarters would break operating leverage thesis
Full multi-lens equity analysis